4893 items matching your search terms.

Progression free survival is a valid surrogate end point for overall survival in first line treatment of advanced epithelial ovarian cancer

Sjoquist, K Lee, C Lord, S Chatfield, M Friedlander, M Simes, RJ Marschner, I

Losing your marble(s): a cross-sectional study of psychosocial outcomes in Australian testicular cancer survivors

Smith, AB King, M Butow, P Luckett, T Grimison, P Toner, G Stockler, M Hovey, E Stubbs, J Olver, I

Quality of life and coping in ovarian cancer: the last year of life

Sommeijer, DW Price, MA Bell, M Friedlander, D Stockler, M deFazio, A Webb, PM Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study Quality of Life Study Investigators, Butow, PN

Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)

Sorbye, H Mauer, M Gruenberger, T Glimelius, B Poston, GJ Schlag, PM Rougier, P Bechstein, WO Primrose, JN Walpole, ET Finch-Jones, M Jaeck, D Mirza, D Parks, RW Collette, L Van Cutsem, E Scheithauer, W Lutz, MP Nordlinger, B EORTC Gastro-Intestinal Tract Cancer Group, Cancer Research UK (CRUK), Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO), Australasian Gastro-Intestinal Trials Group (AGITG), Fédération Francophone de Cancérologie Digestive (FFCD),

Plasma asymmetric dimethylarginine levels correlate with peripheral arterial disease severity but not coronary artery disease

Stanton, KM Rao, SD Assimes, T Wang, BY McGee, S Harada, RK Wilson, A Narasimhan, B Donoghoe, M Brown, C Keech, A Olin, JW Cooke, JP Ng, MK

Histomorphometric and radiographic changes after implantation of peek-interspinous device in the BB.4S rat model

Staub, L

Linking the evidence: intermediate outcomes in medical test assessments

Staub, LP Dyer, S Lord, SJ Simes, RJ
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012     DOI:10.1017/S0266462311000717

Judging when improved test accuracy will lead to improved treatment outcomes

Staub, LP Lord, SJ Irwig, LM Simes, RJ

Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation

Staub, LP Lord, SJ Simes, J Dyer, S Houssami, N Chen, RY Irwig, L
BMC MEDICAL RESEARCH METHODOLOGY, 2012     DOI:10.1186/1471-2288-12-12; ;

Statistical analysis of individual participant data meta-analyses: a comparison of methods and recommendations for practice

Stewart, GB Altman, DG Askie, LM Duley, L Simmonds, MC Stewart, LA
PLOS ONE, 2012     DOI:10.1371/journal.pone.0046042

SORCE study update

Stockler, M

Using scenarios to explain survival time: attitudes of people with a cancer experience

Stockler, MR Kiely, BE McCaughan, GJ Christodoulou, S Beale, PJ Trotman, J Grimison, P Tattersall, MHN

Why Is management of cancer pain still a problem? [editorial]

Stockler, MR Wilcken, NR

Holmium:YAG laser enucleation of the prostate (HoLEP) for the treatment of benign prostatic hyperplasia. MSAC application 1149 assessment report

Stoklosa, A Wortley, S Gould, T Lewis, S Flattery, M

Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial

Sullivan, D Olsson, AG Scott, R Kim, JB Xue, A Gebski, V Wasserman, SM Stein, EA
JAMA, 2012     DOI:10.1001/jama.2012.25790